Autoimmune Disease Testing Market: In-Depth Analysis of the USD 24.14 Billion Forecast by 2031

6

The global autoimmune disease testing market is poised to experience significant growth in the coming years, driven by increasing prevalence of autoimmune diseases and advancements in diagnostic technologies. According to recent market analysis, the market size was valued at USD 11.24 billion in 2023 and is projected to reach USD 24.14 billion by 2031, growing at a remarkable compound annual growth rate (CAGR) of 10.27% during the forecast period of 2024-2031.

Key Players: Major key players in the autoimmune disease testing market include:

  • Abbott Laboratories
  • Siemens Healthineers AG
  • Thermo Fisher Scientific, Inc.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • bioMérieux SA
  • Quidel Corporation
  • Euroimmun AG (a PerkinElmer company)
  • Myriad Genetics, Inc.
  • Hologic, Inc.
  • Other prominent players

Market Analysis: The growth of the autoimmune disease testing market is driven by several key factors, including:

  • Increasing Prevalence of Autoimmune Diseases: The rising prevalence of autoimmune diseases globally, such as rheumatoid arthritis, lupus, and multiple sclerosis, is driving the demand for accurate and early diagnostic testing.
  • Advancements in Diagnostic Technologies: Continuous advancements in diagnostic technologies, including biomarker-based assays, immunoassays, and molecular diagnostics, are enhancing the specificity and sensitivity of autoimmune disease testing, thereby fueling market growth.
  • Growing Adoption of Point-of-Care (POC) Testing: The increasing adoption of point-of-care (POC) testing for autoimmune diseases in clinics and hospitals is contributing to market expansion, allowing for rapid diagnosis and timely treatment.

Get Free Sample Copy of Report: https://shorturl.at/RtTpT

KEY SEGMENTS:

By Product Type:

  • Consumables (Assays, Reagents, Kits)
  • Instruments (Automated Instruments, Manual Instruments)

By Test Type:

  • Routine Laboratory Tests
  • Autoantibody Tests
  • Inflammatory Markers Tests
  • Others

By Disease Type:

  • Rheumatoid Arthritis
  • Systemic Lupus Erythematosus (SLE)
  • Multiple Sclerosis
  • Type 1 Diabetes
  • Others

By End User:

  • Hospitals & Clinics
  • Diagnostic Laboratories
  • Research & Academic Institutes

Regional Analysis: North America is expected to dominate the autoimmune disease testing market throughout the forecast period, driven by high healthcare expenditure, advanced healthcare infrastructure, and increasing research and development activities in the region. However, the Asia Pacific region is anticipated to witness the fastest growth rate, owing to rising awareness about autoimmune diseases and improving healthcare infrastructure.

Key Takeaways:

  • The autoimmune disease testing market is poised for substantial growth, driven by the increasing prevalence of autoimmune diseases and advancements in diagnostic technologies.
  • North America is projected to hold the largest market share, while Asia Pacific presents lucrative opportunities for market expansion.
  • Advancements in diagnostic technologies and growing adoption of POC testing are key factors driving market growth.

Ask For Discount:  https://shorturl.at/pVEDA

Other Trending Reports:

Medical Nonwoven Disposable Market Growth

Medical Swabs Market Growth

Medical Tape and Bandage Market Growth

Medical Waste Containers Market Growth

Microcatheters Market Growth

About Us: SNS Insider is a leading market research and consulting agency dominating the global market research industry. Our aim is to provide clients with the knowledge they need to navigate changing circumstances. To deliver current, accurate market data, consumer insights, and opinions, we utilize a variety of techniques including surveys, video talks, and focus groups globally.

Contact Us:

Akash Anand – Head of Business Development & Strategy

Email: info@snsinsider.com

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)

Website: SNS Insider